Karsten Schrör

530 total citations
4 papers, 417 citations indexed

About

Karsten Schrör is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Hematology. According to data from OpenAlex, Karsten Schrör has authored 4 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Cardiology and Cardiovascular Medicine, 2 papers in Internal Medicine and 2 papers in Hematology. Recurrent topics in Karsten Schrör's work include Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Platelet Disorders and Treatments (2 papers) and Venous Thromboembolism Diagnosis and Management (2 papers). Karsten Schrör is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (3 papers), Platelet Disorders and Treatments (2 papers) and Venous Thromboembolism Diagnosis and Management (2 papers). Karsten Schrör collaborates with scholars based in Germany. Karsten Schrör's co-authors include Artur‐Aron Weber, Marina Braun, Bernhard H. Rauch, Alexander Hermann, Thomas Hohlfeld, Diethelm Tschöpe, B. Schwippert, Ellen Bretschneider and Erika Glusa and has published in prestigious journals such as British Journal of Pharmacology, British Journal of Clinical Pharmacology and Thrombosis Research.

In The Last Decade

Karsten Schrör

4 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Karsten Schrör Germany 4 273 131 112 86 65 4 417
Zihui Xiao China 10 406 1.5× 226 1.7× 106 0.9× 217 2.5× 66 1.0× 13 616
James H. Chesebro United States 6 222 0.8× 128 1.0× 52 0.5× 45 0.5× 20 0.3× 8 349
A D Blann United Kingdom 6 121 0.4× 61 0.5× 69 0.6× 47 0.5× 48 0.7× 7 333
Herm Jan M. Brinkman Netherlands 12 225 0.8× 74 0.6× 165 1.5× 174 2.0× 36 0.6× 18 471
Alf‐Åge R. Pettersen Norway 13 233 0.9× 87 0.7× 72 0.6× 74 0.9× 136 2.1× 22 485
Tomohiro Sakamoto Japan 10 170 0.6× 87 0.7× 34 0.3× 39 0.5× 65 1.0× 11 370
James A. Szalony United States 8 180 0.7× 96 0.7× 209 1.9× 75 0.9× 10 0.2× 10 372
Riitta Lassila Finland 9 210 0.8× 81 0.6× 41 0.4× 72 0.8× 12 0.2× 12 351
Tomoya Hara Japan 9 176 0.6× 68 0.5× 100 0.9× 60 0.7× 37 0.6× 21 364
H.-J. Hertfelder Germany 12 76 0.3× 66 0.5× 122 1.1× 37 0.4× 66 1.0× 28 371

Countries citing papers authored by Karsten Schrör

Since Specialization
Citations

This map shows the geographic impact of Karsten Schrör's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karsten Schrör with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karsten Schrör more than expected).

Fields of papers citing papers by Karsten Schrör

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karsten Schrör. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karsten Schrör. The network helps show where Karsten Schrör may publish in the future.

Co-authorship network of co-authors of Karsten Schrör

This figure shows the co-authorship network connecting the top 25 collaborators of Karsten Schrör. A scholar is included among the top collaborators of Karsten Schrör based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karsten Schrör. Karsten Schrör is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

4 of 4 papers shown
1.
Weber, Artur‐Aron, Marina Braun, Thomas Hohlfeld, et al.. (2001). Recovery of platelet function after discontinuation of clopidogrel treatment in healthy volunteers. British Journal of Clinical Pharmacology. 52(3). 333–336. 132 indexed citations
2.
Hermann, Alexander, Bernhard H. Rauch, Marina Braun, Karsten Schrör, & Artur‐Aron Weber. (2001). Platelet CD40 ligand (CD40L) – subcellular localization, regulation of expression, and inhibition by clopidogrel. Platelets. 12(2). 74–82. 206 indexed citations
3.
Schrör, Karsten, et al.. (1999). Specific inhibition of ADP‐induced platelet aggregation by clopidogrel in vitro. British Journal of Pharmacology. 126(2). 415–420. 55 indexed citations
4.
Bretschneider, Ellen, Erika Glusa, & Karsten Schrör. (1994). ADP-, PAF- and adrenaline-induced platelet aggregation and thromboxane formation are not affected by a thromboxane receptor antagonist at physiological external Ca++ concentrations. Thrombosis Research. 75(3). 233–242. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026